Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy and Adverse Events of Docetaxel for Metastatic, Hormone-Sensitive Prostate Cancer Among Elderly Men: A Post Hoc Analysis of the CHAARTED TrialClin Genitourin Cancer 2021 Oct 01;19(5)388-395, EV Li, MR Siddiqui, AB Weiner, AE Prizment, CJ Ryan, AK Morgans
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.